Abstract
Accurate measurement of P-glycoprotein (P-170) expression in clinical samples still remains a controversial issue. In this study tumor cell P-170 expression was assessed in 29 patients suffering from acute leukemia (17 acute myeloid leukemia (AML) and 12 acute lymphoblastic leukemia (ALL)) using three different techniques: flow cytometry measuring rhodamine 123 (Rh123) efflux (functional level), immunocytochemistry (protein level) and RT-PCR (mRNA level). Rh123 efflux was detectable in 10/29 (34%) of all cases, in 9/17 (53%) of AML and in 1/12 (8%) of ALL samples. In AML patients a significant association of CD34 expression and P-170 activity was observed (P < 0.02). all aml patients with the fab subtype m5 were rh123 negative (P < 0.007). cytospin preparations were analyzed for staining with monoclonal antibodies jsb1 and mm4.17. eight of 16 (50%) aml and 0/9 (0%) all cases expressed the multidrug resistance (mdr) protein assessed by jsb1. with mm4.17 87% of aml and 50% of all patients were scored positive. agreement between both antibodies was found in only 13/23 (57%) samples. extracted rna from 12 patients was analyzed by rt-pcr to evaluate the expression of mdr1 and multidrug resistance-associated protein (mrp) mrna. an increased level of mdr1 mrna was detectable in 4/7 aml and 0/5 all cases. mrp expression was found in 3/7 aml and 0/5 all patients. comparison of rh123 assay and immunocytochemistry revealed a very good correlation when using moab jsb1 (P < 0.004) but not with mm4.17 (not significant (ns)). jsb1 also showed a much better association with the pcr results (P < 0.05) than mm4.17 (ns). finally, we compared the results of the functional rh123 assay and rt-pcr and observed a high correlation for rh123/mdr1 (r = 0.819, P < 0.001) but low for rh123/mrp (r = 0.562, NS). We conclude that measurement of Rh123 efflux and immunocytochemical staining of cytospin preparations with JSB1 allows the accurate monitoring of P-170 expression in acute leukemia. The simplicity of these two MDR assays suggests their use for routine MDR screening.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pall, G., Spitaler, M., Hofmann, J. et al. Multidrug resistance in acute leukemia: a comparison of different diagnostic methods. Leukemia 11, 1067–1072 (1997). https://doi.org/10.1038/sj.leu.2400691
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400691
Keywords
This article is cited by
-
Methods and goals for the use of in vitro and in vivo chemosensitivity testing
Molecular Biotechnology (2007)